Robert Beauchamp
Principal Investigator
Last active: 10/31/2018

  1. New strategies for colorectal cancer prevention and treatment. Saha D, Roman C, Beauchamp RD (2002) World J Surg 26(7): 762-6
    › Primary publication · 11948369 (PubMed)
  2. Induction of cyclooxygenase-2 and invasiveness by transforming growth factor-beta(1) in immortalized mouse colonocytes expressing oncogenic Ras. Roman CD, Morrow J, Whitehead R, Beauchamp RD (2002) J Gastrointest Surg 6(3): 304-9
    › Primary publication · 12022979 (PubMed)
  3. Identification and isolation of candidate human colonic clonogenic cells based on cell surface integrin expression. Fujimoto K, Beauchamp RD, Whitehead RH (2002) Gastroenterology 123(6): 1941-8
    › Primary publication · 12454851 (PubMed)
  4. Cyclin D3 is essential for intestinal epithelial cell proliferation. Ko TC, Pan F, Sheng H, Brown DB, Thompson EA, Beauchamp RD (2002) World J Surg 26(7): 812-8
    › Primary publication · 11948368 (PubMed)
  5. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells. Fujimoto K, Sheng H, Shao J, Beauchamp RD (2001) Exp Cell Res 266(2): 239-49
    › Primary publication · 11399052 (PubMed)
  6. TGF-beta and colorectal carcinogenesis. Roman C, Saha D, Beauchamp R (2001) Microsc Res Tech 52(4): 450-7
    › Primary publication · 11170304 (PubMed)
  7. Oncogenic ras represses transforming growth factor-beta /Smad signaling by degrading tumor suppressor Smad4. Saha D, Datta PK, Beauchamp RD (2001) J Biol Chem 276(31): 29531-7
    › Primary publication · 11371552 (PubMed)
  8. Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Deane NG, Parker MA, Aramandla R, Diehl L, Lee WJ, Washington MK, Nanney LB, Shyr Y, Beauchamp RD (2001) Cancer Res 61(14): 5389-95
    › Primary publication · 11454681 (PubMed)
  9. A phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignancies. Blanke CD, Stipanov M, Morrow J, Rothenberg M, Chinery R, Shyr Y, Coffey R, Johnson DH, Leach SD, Beauchamp RD (2001) Invest New Drugs 19(1): 21-7
    › Primary publication · 11291830 (PubMed)
  10. Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. Sheng H, Shao J, Dixon DA, Williams CS, Prescott SM, DuBois RN, Beauchamp RD (2000) J Biol Chem 275(9): 6628-35
    › Primary publication · 10692471 (PubMed)